UNH vs. CVS: Wall Street Weighs Healthcare Stocks Amid Sector Recovery
UnitedHealth Group and CVS Health are drawing analyst attention as the healthcare sector stabilizes. UnitedHealth, despite a 37% decline in 2025 due to regulatory scrutiny and leadership changes, has seen a 4% rebound in recent months. Bernstein's upgraded price target to $379 reflects cautious optimism.
CVS Health leverages its dual role as insurer and pharmacy benefits manager, positioning it as a resilient play. Neither stock directly ties to cryptocurrency markets, but the broader theme of institutional confidence echoes crypto's maturation narrative.